[89Zr]Df-IAB22M2C Anti-CD8 Minibody PET/CT Imaging to Assess the in Vivo Distribution of CD8+ T-cells in COVID-19 Patients
Latest Information Update: 07 May 2024
At a glance
- Drugs Crefmirlimab (Primary)
- Indications Lymphopenia
- Focus Diagnostic use
- Acronyms Tangelo
- 05 May 2024 Status changed from recruiting to discontinued.
- 02 Jun 2022 Status changed from not yet recruiting to recruiting.
- 02 Jun 2022 Planned End Date changed from 1 Sep 2022 to 1 Dec 2022.